Significant Ownership of BIOS Capital Management, LP

Location
Fort Worth, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BIOS Capital Management, LP.

Notify me when BIOS Capital Management, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of BIOS Capital Management, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LTRN Lantern Pharma Inc. Common Stock, par value $0.0001 per share 8.6% $2,908,879 -$351,256 960,026 -11% BIOS CAPITAL MANAGEMENT, LP 20 Feb 2026
INAB IN8BIO, INC. Common Stock, par value $0.0001 per share 4% $849,245 -$18,941,314 391,357 -96% BIOS Capital Management, LP 22 Dec 2025

Schedules 13D/G Reported by BIOS Capital Management, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.